melanoma

EXPERIENCE OF USING PD-1 CHECKPOINT INHIBITOR PROLGOLIMAB IN REAL CLINICAL PRACTICE IN A PATIENT WITH MULTIPLE METASTASES OF MELANOMA FROM AN UNKNOWN PRIMARY SITE

от

V.E. Askarov1, K.V. Menshikov1,2, Sh.I. Musin1, A.F. Nasretdinov1, N.I. Sultanbaeva1, I.A. Menshikova2, A.V. Sultanbaev1 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Askarov Vadim E. ― oncologist, head of the anti-tumor drug therapy department of the Republican Clinical Oncology Dispensary (Sterlitamak branch) 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, e-mail: ufa.askarov@gmail.com, ORCID ID: … Читать далее

PROLGOLIMAB IN THE FIRST LINE OF TREATMENT OF METASTATIC MELANOMA. LITERATURE REVIEW. CLINICAL OBSERVATION

от

K.V. Menshikov1,2, A.V. Sultanbaev1,2, Sh.I. Musin1, R.B. Valiakhmedov1, V.S. Chalov3, M.M. Zamilov1, I.A. Menshikova2, N.I. Sultanbaeva1, I.I. Abdullin1, R.F. Zakirova1 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa 3LLC «PET-Technology Center» OP «Center for Nuclear Medicine in Ufa», Ufa Menshikov Konstantin V. ― Cand. of Sci. (Med.), Associate Professor of the Department of … Читать далее

RARE MALIGNANT TUMORS IN CLINICAL ONCOPROCTOLOGY: A SINGLE-CENTER 20 YEARS RETROSPECTIVE ANALYSIS

от

S.S. Gordeev1, Z.N. Magarramova1,2, V.S. Myshlyakov1,2, Z.Z. Mamedli1, I.S. Stilidi1 1N.N. Blokhin National Medical Research Center of Oncology, Moscow 2A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow Gordeev Sergey S. — Cand. of Sci. (Med.), leading researcher of the Oncological Department of Surgical methods of treatment №3 (coloproctology) of the N.N. Blokhin National … Читать далее